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ABSTRACT
Group B streptococcus (GBS) remains the most common cause of early-onset sepsis in newborns. Laboratory
gold-standard, broth culture methods are highly specific, but lack sensitivity. The aim of this study was to
validate a nested-PCR and to determine whether residue volumes of urine samples obtained by non invasive,
non sterile methods could be used to confirm neonatal GBS sepsis. The nested-PCR was performed with
primers of the major GBS surface antigen. Unavailability of biological samples to perform life supporting
exams, as well as others to elucidate the etiology of infections is a frequent problem concerning newborn
patients. Nevertheless, we decided to include cases according to strict criteria: newborns had to present with
signs and symptoms compatible with GBS infection; at least one of the following biological samples had to be
sent for culture: blood, urine, or cerebrospinal fluid; availability of residue volumes of the samples sent for
cultures, or of others collected on the day of hospitalization, prior to antibiotic therapy prescription, to be
analyzed by PCR; favorable outcome after GBS empiric treatment. In only one newborn GBS infection was
confirmed by cultures, while infection was only presumptive in the other three patients (they fulfilled inclusion
criteria but were GBS-culture negative). From a total of 12 biological samples (5 blood, 3 CSF and 4 urine
specimen), eight were tested by culture methods (2/8 were positive), and 8 were tested by PCR (7/8 were
positive), and only 4 samples were simultaneously tested by both methods (1 positive by culture and 3 by
PCR). In conclusion, although based on a restricted number of neonates and samples, our results suggest
that the proposed nested-PCR might be used to diagnose GBS sepsis as it has successfully amplified the
three types of biological samples analyzed (blood, urine and cerebrospinal fluid), and was more sensitive than
culture methods as PCR in urine confirmed diagnosis in all four patients. Moreover, PCR has enabled us to
use residue volumes of urine samples collected by non invasive, non sterile methods, what is technically
adequate as GBS is not part of the normal urine flora, thus avoiding invasive procedures such as suprapubic
bladder punction or transurethral catheterization. At the same time, the use of urine instead of blood samples
could help preventing newborns blood spoliation.
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INTRODUCTION
Group B streptococcus (GBS) remains the most common
cause of early-onset sepsis, meningitis and pneumonia in
newborns (3), albeit a considerable reduction of cases in
developed countries due to the nearly universal use of intra-
partum prophylaxis for maternal GBS carriage (12). Broth culture,
the current laboratory gold-standard is highly specific, but lacks
sensitivity especially in neonates who are normally receiving
antibiotics prior to hospitalization and culture sampling. More
recently, PCR has proved to be a useful diagnostic tool due to
its increased sensitivity and specificity to detect either broad-
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range bacterial agents associated to neonatal sepsis (12), or
more specifically GBS (10).
The aim of this study was to validate a nested-PCR and to
determine whether residue volumes of urine collected by a non
invasive, non sterile method could be used to confirm neonatal
GBS sepsis.
MATERIAL AND METHODS
Blood, CSF and urine cultures were performed in Todd-Hewitt
broth supplemented with antibiotics (5). DNA extractions from
blood were performed according to a protocol described
elsewhere (2). CSF and urine DNA were extracted from 200 µL of
samples using QIAamp DNA blood mini kit (Qiagen, Valencia,
CA) (1). The first and the second PCR were performed in 50 µL
of total volume containing 20 µL of DNA from blood, urine or
CSF samples, 100 mM of Tris-HCl and 500 mM of KCl; 2.5 units
of Taq DNA polymerase (Amersham Biotech, USA), 200 µM of
dNTP (Amersham), 2.5 mM of MgCl2; and 0.4 µM of each primer
from the major GBS surface antigen (SAG). The outer primers
were designed in our laboratory: CFB-Sb (sense) 5’-
ATGATGTATCTATCTGGAACTCTAGT G-3’ and CFB-Ab
(anti-sense) 5’-CGCAATGAAGTCTTTAATTTTTC-3’ while the
inner primers were described elsewhere (7,8): An initial
denaturation step of 5 minutes at 95ºC was followed by 40 cycles
of 1 minute at 95ºC, 1 minute at 50ºC and 1 minute at 72ºC. A final
extension time of 5 minutes at 72ºC has ended amplifications
(M.J. Research PT-150), in both rounds. Nested-PCR produced
DNA fragments of 259 bp and 153 bp which were visualized in
2% ethidium bromide-stained agarose gels (Sigma, USA). In
each experiment, negative controls (sterile water instead of
genomic DNA), DNA from a non-infected individual, as well as
a positive control (GBS-DNA from cultures) were included. All
preventive measures were applied in order to minimize the risk
of contamination with GBS-positive samples or pre-amplified
products. The nested-PCR was able to detect as few as 1
fentogram of GBS-DNA after the second round of amplification
(1.0 CFU is equivalent to 0.01 pg) (6).
RESULTS
All four newborns received penicillin or penicillin-derived
antibiotics to treat GBS sepsis and evolved favorably. A total of
12 samples (5 blood, 3 CSF and 4 urine specimen) from the four
newborns were tested either by culture (n=8), or by PCR (n=8).
Amplification of some of the biological samples tested is shown
in Fig. 1.
Table 1 summarizes culture and PCR results of the four
patients.
In patient number 1 GBS infection was confirmed by blood
and CSF cultures (no urine sample sent for culture). Although
we could not obtain blood to perform PCR in this case,
Table 1. Description of patients, biological samples, culture and
nested-PCR results. NT= not tested (no residual volume of
sample available). Eight samples (B1, C1, B2, C2, U2, B3, B5 and
C3) were sent for culture, and 8 samples (C1, U1, B2, C2, U2, B4,
U3 and U4) were analyzed by PCR. Four samples were
simultaneously analyzed by culture methods and PCR (C1, B2,
C2, U2, represented in bold).
Newborn Biological GBS- Nested-
Sample Culture PCR
blood B1 - positive NT
1 CSF C1- positive C1 - positive
urine NT U1- positive
blood B2- negative B2- positive
2 CSF C2- negative C2- negative
urine U2 - negative U2- positive
blood B3- negative B4- positive
3 CSF NT NT
urine NT U3- positive
blood B5 - negative NT
4 CSF C3- negative NT
urine NT U4 - positive
Figure 1. Electrophoresis of the nested-PCR amplification
products in 2% agarose gels. A – first round. B – second
round. M - Molecular weight marker - 100 bp (Amersham), lane
1 – negative control (sterile water instead of DNA); lane 2 -
human GBS-free DNA (negative control); lane 3 – CSF of patient
1; lane 4 – CSF of patient 2; lane 5 – blood of patient 3; lane 6-
urine of patient 4; 7- positive control (GBS-DNA). Samples of
lanes 3 and 5 were positive from the first round, while sample of
lane 6 was positive only after the second round of amplification.
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amplifications yielded positive results in one aliquot of the same
CSF sample sent for culture, and in one urine sample collected
on the day of hospitalization, before antibiotic therapy was
prescribed. In patient number 2 who presented with negative
blood, CSF and urine cultures, it was possible to test the same
three biological samples, and PCR resulted positive in blood
and urine, but negative in CSF. In newborn number 3, one blood
sample was sent for culture and resulted negative (no CSF or
urine sample were sent for culture), while PCR was positive in
another blood sample and in one urine specimen, both collected
on the day of hospitalization, prior to antibiotic therapy. In
newborn number 4, blood and CSF cultures were negative (no
urine sample was sent for culture), while PCR was positive in
one urine sample, obtained on the day of hospitalization, before
antibiotics prescription (other blood samples and CSF aliquots
were not available).
Considering the biological samples irrespective of the
patients (see Table 1), eight were tested by culture methods (4
blood, 3 CSF and 1 urine specimen, corresponding to B1, C1,
B2, C2, U2, B3, B5 and C3) resulting in 2 positive detections,
while 8 were tested by PCR (2 blood, 2 CSF and 4 urine specimen,
corresponding to C1, U1, B2, C2, U2, B4, U3 and U4), yielding 7
positive detections. In only four instances the same biological
materials were simultaneously analyzed by culture and PCR (1
blood, 2 CSF and 1 urine specimen, corresponding to C1, B2, C2
and U2) resulting in 1 culture-positive and 3 PCR-positive
samples.
DISCUSSION
Only a few studies have analyzed biological samples from
neonates to detect GBS by molecular techniques, and in the
majority of cases using stored biological material instead of
freshly obtained specimen (4,9). We decided to follow very
restrictive inclusion criteria of patients in the present study
even though they had significantly decreased the number of
cases enrolled, in an attempt to circumvent the possibility of
GBS-culture negativity due to previous administration of
antibiotics to the newborns rather than to other etiology of
infections, although PCR performance could also be affected,
probably in a lesser extent. These criteria have also faced the
difficulty to find residue volumes of biological samples available
for PCR analysis, taken into account that they should had been
taken on the same day of hospitalization, prior to antibiotic
administration.
In neonatology, the amount of biological samples required
to perform life-supporting exams, as well as others to investigate
the etiology of infections constitutes a limiting factor for
laboratory diagnosis. Moreover, culture methods are almost as
expensive as molecular techniques, time consuming and
sometimes lack sensitivity, e.g. in neonates who have previously
received antibiotics. It is true that a negative PCR cannot rule
out GBS infection either, however, PCR has been reported to be
more sensitive (6,7,11), as occurred in the present study. The
proposed nested-PCR was able to detect GBS-DNA in blood,
CSF and urine, thus being suitable to analyze these three types
of biological samples. Besides, the nested-PCR was more
sensitive than culture methods as it has confirmed diagnosis in
the four newborns studied, while cultures were negative in three
(presumptive GBS sepsis cases). It is also important to
emphasize that nested-PCR was able to confirm GBS infection
in residue volumes of urine collected by non invasive, non
sterile method, what is technically adequate considering that
GBS is not part of the normal urine flora. At the same time, the
use of urine instead of blood samples could help preventing
newborns blood spoliation.
RESUMO
Diagnóstico de sepse neonatal causada pelo
estreptococo do grupo B por meio de dupla
amplificação de amostras residuais de urina
O estreptococo do grupo B (GBS) constitui a causa mais
freqüente de sepse neonatal precoce. O teste de referência
continua sendo o isolamento em cultura, apesar de apresentar
problemas de sensibilidade. O objetivo do presente estudo foi
validar uma técnica de dupla amplificação e determinar a
possibilidade do uso de amostras residuais de urina colhidas
por método não invasivo, não estéril, para a confirmação da
sepse por GBS em recém-nascidos. As amostras foram
amplificadas com primers do principal gene de superfície do
GBS. A insuficiência de volume de material biológico para a
realização de exames para suporte de vida, além de outros
necessários à identificação do agente etiológico de infecções é
muito freqüente em recém-nascidos. Mesmo assim, decidimos
definir critérios bastante rigorosos para a inclusão de pacientes
na casuística: os recém-nascidos deveriam apresentar sinais e
sintomas compatíveis com infecção pelo GBS; deveriam ter tido
ao menos uma amostra enviada para cultura, podendo ser
sangue, urina ou líquor; disponibilidade de volumes residuais
dessas amostras, ou de outras colhidas no dia da hospitalização,
antes da introdução da antibioticoterapia, de forma a possibilitar
a análise por PCR, e evolução favorável com a antibioticoterapia
empírica. Em apenas um dos quatro recém-nascidos a infecção
foi confirmada por cultura, enquanto nos outros três casos a
infecção foi considerada presuntiva (pacientes preencheram
os critérios de inclusão, mas o GBS não foi isolado). De um total
de 12 amostras dos quatro pacientes (5 de sangue, 3 de líquor e
4 de urina), 8 foram testadas por cultura (2 foram positivas), 8
foram testadas por PCR (7 foram positivas), e apenas 4 pelos
dois métodos simultaneamente (1 positiva por cultura e 3 por
PCR). Concluímos que apesar do número restrito de pacientes e
de amostras testadas, os resultados apresentados sugerem que
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a amplificação proposta poderia ser usada para o diagnóstico
de sepse pelo GBS, uma vez que a amplificação foi possível nos
três tipos de materiais biológicos testados (sangue, urina e
líquor), e a PCR foi mais sensível que as culturas por ter
conseguido confirmar a infecção na urina dos quatro pacientes,
usando volumes residuais de amostras colhidas por método
não invasivo, não estéril, o que é tecnicamente adequado uma
vez que o GBS não faz parte da flora normal da urina, evitando
procedimentos invasivos, tais como a punção supra-púbica da
bexiga ou a cateterização transuretral. Ao mesmo tempo, o uso
de urina em lugar de sangue ajuda a prevenir a espoliação
sangüínea dos recém-nascidos.
Palavras-chave: Estreptococo do grupo B, sepse neonatal, sepse
neonatal precoce, infecção neonatal, PCR, dupla amplificação
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